Q32 Bio Inc.
Nasdaq: QTTB
- Raised $84 million (2017)
- 8 clinical trials, 3 active
- Founded 2015
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
SignalRX Pharmaceuticals, Inc
- Raised $250,000 (2023)
- 2 clinical trials
- Research grants: $5.9 million
Siloam Vision, Inc.
- Raised $350,000 (2026)
- 2 clinical trials, 1 active
- Research grants: $5.7 million
- Founded 2021
STERIS Ltd
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Subtle Medical, Inc.
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $6.3 million
West Pharmaceutical Services Inc
NYSE: WST
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Neuronetics, Inc.
Nasdaq: STIM
- Raised $15 million (2017)
- FDA-cleared or approved devices
Stemline Therapeutics Inc
- Raised $740,000 (2012)
- 22 clinical trials, 10 active
- Research grants: $349,570
Filana Therapeutics, Inc.
Nasdaq: FLNA
- Raised $1.1 million (2018)
- 16 clinical trials
TESARO, Inc.
- Raised $50 million (2016)
- 33 clinical trials, 5 active
- Founded 2010
Absci Corp
Nasdaq: ABSI
- Raised $70 million (2021)
- 1 clinical trial, 1 active
- Founded 2020
Adial Pharmaceuticals, Inc.
Nasdaq: ADIL
- Raised $4.3 million (2025)
- 1 clinical trial
- Founded 2017
Aditxt, Inc.
OTC: ADTX
- Raised $6 million (2024)
- 1 clinical trial
- Founded 2017
Alpha Cognition Inc.
Nasdaq: ACOG
- Raised $4.5 million (2024)
- 1 clinical trial, 1 active
- Founded 2017
Ancilia Biosciences, Inc.
- Raised $1 million (2023)
- 1 clinical trial, 1 active
- Research grants: $548,802
- Founded 2019
Biofrontera Inc.
Nasdaq: BFRI
- Raised $11 million (2025)
- 3 clinical trials, 1 active
Brainbox Solutions, Inc.
- Raised $7.1 million (2023)
- 1 clinical trial
- Research grants: $943,670
- Founded 2018
Ceresti Health, Inc.
- Raised $10 million (2026)
- 1 clinical trial, 1 active
- Research grants: $956,214
- Founded 2013
Certara
On BioBridgeX
- Raised $8.6 million (2026)
- 4 clinical trials, 1 active
- Founded 2017
Constellation Pharmaceuticals Inc
- Raised $65 million (2019)
- 7 clinical trials
- Founded 2008
Corcept Therapeutics Inc
Nasdaq: CORT
- Raised $525,305 (2012)
- 73 clinical trials, 9 active
Coya Therapeutics, Inc.
Nasdaq: COYA
- Raised $10 million (2024)
- 1 clinical trial, 1 active
- Founded 2020
Electra Therapeutics, Inc.
Nasdaq: ETRA
- Raised $134 million (2025)
- 3 clinical trials, 2 active
Imaginab, Inc.
- Raised $7.7 million (2017)
- 9 clinical trials
- Research grants: $6 million
- Founded 2009
Indaptus Therapeutics, Inc.
Nasdaq: INDP
- Raised $2.3 million (2025)
- 1 clinical trial, 1 active
- Founded 2021
Jazz Pharmaceuticals plc
Nasdaq: JAZZ
- Private funding (2009)
- 207 clinical trials, 26 active
Kezar Life Sciences, Inc.
Nasdaq: KZR
- Raised $50 million (2017)
- 7 clinical trials
- Founded 2015
Lantern Pharma Inc.
Nasdaq: LTRN
- Raised $2.4 million (2019)
- 4 clinical trials, 3 active
Mimivax Inc.
- Raised $5.8 million (2024)
- 1 clinical trial
- Research grants: $927,958
- Founded 2011
MindMaze Therapeutics Holding SA
OTC: MMTZF
- Raised $16 million (2021)
- 3 clinical trials, 1 active
NanoCellect Biomedical, Inc.
- Raised $29 million (2023)
- Research grants: $20 million
- Founded 2011
NexImmune, Inc.
- Raised $7.8 million (2019)
- 3 clinical trials, 1 active
- Research grants: $288,268
- Founded 2011
NuPulseCV, Inc.
- Raised $2.1 million (2020)
- 1 clinical trial
- Research grants: $1.4 million
- Founded 2010
Parabilis Medicines, Inc.
Nasdaq: PBLS
- Raised $178 million (2022)
- 1 clinical trial, 1 active
- Founded 2015
Passage BIO, Inc.
Nasdaq: PASG
- Raised $110 million (2019)
- 1 clinical trial, 1 active
- Founded 2017
PharmaIN Corp
- Raised $1.5 million (2014)
- 1 clinical trial, 1 active
- Research grants: $34 million
Phio Pharmaceuticals Corp.
Nasdaq: PHIO
- Raised $1.4 million (2025)
- 2 clinical trials, 1 active
- Founded 2011
Protara Therapeutics, Inc.
Nasdaq: TARA
- Raised $22 million (2017)
- 15 clinical trials, 4 active
TG Therapeutics, Inc.
Nasdaq: TGTX
- Raised $11 million (2012)
- 3 clinical trials
Unicycive Therapeutics, Inc.
Nasdaq: UNCY
- Raised $50 million (2024)
- 1 clinical trial
- Founded 2016
Pulse Therapeutics, Inc.
- Raised $5.6 million (2016)
- 2 clinical trials
- Research grants: $8.3 million
- Founded 2008
Rivanna Medical, LLC
- Raised $3 million (2016)
- FDA-cleared or approved devices
- Research grants: $28 million
Senseonics, Inc
- Raised $10 million (2015)
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
Contego Medical Inc
- Raised $23 million (2023)
- 5 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2019
Tasso, Inc
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $2.8 million
Amygdala Neurosciences Inc
- Raised $5.6 million (2019)
- 1 clinical trial
- Research grants: $4.6 million
- Founded 2015
BehaVR, Inc.
- Raised $7.2 million (2021)
- 2 clinical trials, 1 active
- Research grants: $5.6 million
- Founded 2016
Chrono Therapeutics Inc.
- Raised $38 million (2016)
- 1 clinical trial
- Research grants: $12 million
Mellitus, LLC
- Raised $90,000 (2023)
- 1 clinical trial
- Research grants: $7.1 million
- Founded 2011
Renova Therapeutics, Inc.
- Raised $166,500 (2024)
- 1 clinical trial
- Research grants: $7.1 million
Published company profiles only; counts update daily. Data licences